The study’s findings suggest that the selected herbal compounds, particularly those targeting TGF-β and TNF-α, could be broadly applicable in treating liver fibrosis across different etiologies of chronic liver disease (Table 3). This evidence concerns the gene TGFB1 and Hepatic fibrosis.